Cognate is a dynamic, results-driven, organization focused on providing the broadest range of commercialization services to regenerative medicine and advance cell therapy companies, organizations and institutions. Cognate provides specialized custom services to companies across all points of clinical and commercial development ranging from early preclinical studies, to mid phase trials and product scale-up  though later stage clinical trials and commercial manufacturing.